Biomarin Pharmaceutical Inc
$12.07B- Market cap
- $12.88B
- Debt
- +$505.32M
- Cash
- −$1.31B
Capital structure 96% equity / 4% debt · EV / Revenue 3.75x · EV / EBITDA 21.37x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
BMRN · current priceP/S 4.00x
$66.53Latest market snapshot
Implied fair value · at GTLB's multiple
$146.98120.9% above market
16.64 BMRN revenue / share×8.83x GTLB P/S=$146.98
Market $66.53Implied $146.98
GTLB · current priceP/S 8.83x
$49.83Latest market snapshot
Implied fair value · at BMRN's multiple
$22.9054.1% below market
5.73 GTLB revenue / share×4.00x BMRN P/S=$22.90
Market $49.83Implied $22.90